Related Experiment Video

Updated: May 22, 2026

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

Chronic myeloid leukaemia and human immunodeficiency virus (HIV) infection

Michael J Webb1, Claire L Barrett, Christel Pretorius

  • 1Division of Clinical Haematology, Department of Internal Medicine (G73), Faculty of Health Sciences, University of the Free State, PO Box 339, Bloemfontein, 9300, South Africa. webbmj@ufs.ac.za

International Journal of Hematology
|April 25, 2012
PubMed

Insights

Managing chronic myeloid leukaemia (CML) in human immunodeficiency virus (HIV) patients presents unique challenges. Careful management can lead to positive long-term outcomes despite compliance issues and specific side effects.

Area of Science:

  • Hematology
  • Oncology
  • Infectious Diseases

Background:

  • Co-occurrence of chronic myeloid leukaemia (CML) and human immunodeficiency virus (HIV) is rare.
  • Limited literature exists on managing CML in HIV-positive patients.

Purpose of the Study:

  • To describe the management experience of 10 CML patients with HIV co-infection.
  • To analyze demographic data, disease characteristics, and treatment responses.

Main Methods:

  • Retrospective analysis of 10 CML patients with HIV co-infection at a single center.
  • Review of patient demographics, CML characteristics, therapy, and outcomes.

Main Results:

  • Predominance of black females observed in the patient cohort.
  • A minority of patients achieved complete cytogenetic response, often linked to compliance issues.
  • Side effect profile was generally as expected, with one case of drug rash with eosinophilia and systemic symptoms.

Conclusions:

  • CML patients with HIV co-infection face distinct challenges.
  • Appropriate management is crucial for achieving positive long-term outcomes.
  • Compliance, influenced by factors like treatment center distance, impacts treatment success.

More Related Videos

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals06:46

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals

Published on: January 5, 2016

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...